Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

pembrolizumab 26 Pemetrexed 26 Cisplatin 25 Nivolumab 22 Carboplatin 16 Paclitaxel 14 Gemcitabine 12 Ipilimumab 11 tislelizumab 8 durvalumab 8 Ramucirumab 8 Docetaxel 8 talazoparib 7 Fluorouracil 7 Radiotherapy 6 Capecitabine 6 tremelimumab 5 cobimetinib 5 atezolizumab 5 adavosertib 5 Radiosurgery 5 Cyclophosphamide 5 Bevacizumab 5 olaparib 4 avelumab 4 Temozolomide 4 Sunitinib 4 Specimen Handling 4 Platinum 4 PM 01183 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × MK-4166 × Other solid neoplasm × Clear all

NCT02132754 2021-01-28

MK-4166-001

Merck Sharp & Dohme LLC

Phase 1 Completed

116 enrolled 61 charts

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡